Cyclacel suspends preferred stock dividend; replaces Board Chair, defers CEO salary

Bio Green Med Solution, Inc.

Suspended quarterly cash dividend on 6% Convertible Exchangeable Preferred Stock (CYCCP) scheduled for Aug 1, 2024; board will evaluate quarterly.
Dr. Samuel L. Barker appointed Chair of board; Dr. Christopher Henney stepped down as Chair but remains director.
CEO Spiro Rombotis agreed to defer $22,000/month of salary until Dec 31, 2024; amount forfeited if not paid by then.
Stockholders approved amendment to 2018 Equity Incentive Plan, reserving additional 160,000 shares of common stock.
All three Class 3 director nominees (Henney, McBarron, Spiegel) re-elected; RSM US LLP ratified as auditor.

item 5.02 item 5.07 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Samuel L. Barker

Chair of the board

BGMS · Bio Green Med Solution, Inc.

Effective: 2024-06-21
Successor: Dr. Christopher Henney
Filed: June 25, 2024, 7:59 PM ET

Effective June 21, 2024, by resolution of the board of directors of the Company, Dr. Samuel L. Barker was appointed Chair of the board of directors to replace Dr. Christopher Henney, who requested to step down as Chair but will continue as a director of the Company.

Role change

Dr. Christopher Henney

Director

BGMS · Bio Green Med Solution, Inc.

Effective: 2024-06-21
Successor: Dr. Samuel L. Barker
Filed: June 25, 2024, 7:59 PM ET

Effective June 21, 2024, by resolution of the board of directors of the Company, Dr. Samuel L. Barker was appointed Chair of the board of directors to replace Dr. Christopher Henney, who requested to step down as Chair but will continue as a director of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Samuel L. Barker was appointed as Chair of the board at Bio Green Med Solution, Inc..

Action: appointed
Role: Chair of the board

Exact text from the filing

Effective June 21, 2024, by resolution of the board of directors of the Company, Dr. Samuel L. Barker was appointed Chair of the board of directors to replace Dr. Christopher Henney, who requested to step down as Chair but will continue as a director of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Christopher Henney changed role as Director at Bio Green Med Solution, Inc..

Action: stepped down as Chair
Role: Director

Exact text from the filing

Effective June 21, 2024, by resolution of the board of directors of the Company, Dr. Samuel L. Barker was appointed Chair of the board of directors to replace Dr. Christopher Henney, who requested to step down as Chair but will continue as a director of the Company.

View on SEC.gov

Bio Green Med Solution, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-074467

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.